Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccines

被引:12
作者
Tozzi, AE
degli Atti, MLC
Wassilak, SGF
Salmaso, S
Panei, P
Anemona, A
Luzi, S
Greco, D
机构
[1] Ist Super Sanita, Epidemiol & Biostat Lab, Reparto Malattie Infett, I-00161 Rome, Italy
[2] NIAID, NIH, Bethesda, MD 20892 USA
关键词
pertussis; acellular vaccine; whole-cell vaccine; DT; safety;
D O I
10.1016/S0264-410X(97)00163-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recurrence of adverse events, the effect of sire of injection, and concurrent administration of oral polio vaccine (OPV) and hepatitis B vaccine (HBV) on reactogenicity were assessed in recipients of two acellular pertussis vaccines given in combination with diphtheria and tetanus toxoids (DTaP), one whole-cell DTP vaccine (DTPwc) and one DT vaccine during a double blind, randomized, controlled clinical trial. Local and systemic side reactions were more likely to recur after the administration of DTaP and DT compared with DTPwc, In all vaccine groups, injection in the buttock was associated with a lower rate of common adverse events compared with injection in the thigh, while simultaneous administration of OPV and/or HBV did not increase the risk of onset of side reactions. Published by Elsevier Science Ltd.
引用
收藏
页码:320 / 322
页数:3
相关论文
共 12 条
[1]  
BARAFF LJ, 1984, PEDIATRICS, V73, P31
[2]  
BERGESON PS, 1982, PEDIATRICS, V70, P944
[3]  
DECKER MD, 1995, PEDIATRICS, V96, P557
[4]   A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis [J].
Greco, D ;
Salmaso, S ;
Mastrantonio, P ;
Giuliano, M ;
Tozzi, AE ;
Anemona, A ;
Atti, MLCD ;
Giammanco, A ;
Panei, P ;
Blackwelder, WC ;
Klein, DL ;
Wassilak, SGF ;
Stefanelli, P ;
Bottone, M ;
Sofia, T ;
Luzi, S ;
Bellomi, G ;
Cobianchi, F ;
Canganella, G ;
Meduri, F ;
Scuderi, G ;
Chiarini, A ;
Maggio, M ;
Taormina, S ;
Genovese, M ;
Moiraghi, A ;
Barale, A ;
DiTommaso, S ;
Malaspina, S ;
Vasile, E ;
Ferraro, P ;
DalLago, P ;
DeMarzi, L ;
Robino, L ;
Giraldo, E ;
Coppola, N ;
Materassi, P ;
Castellani, GT ;
Basso, F ;
Barbuti, S ;
Quarto, M ;
Lopalco, P ;
DOrazio, P ;
Sanguedolce, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :341-348
[5]   A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine [J].
Gustafsson, L ;
Hallander, HO ;
Olin, P ;
Reizenstein, E ;
Storsaeter, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :349-355
[6]   COMPARATIVE-STUDY OF LEDERLE TAKEDA ACELLULAR AND LEDERLE WHOLE-CELL PERTUSSIS-COMPONENT DIPHTHERIA-TETANUS-PERTUSSIS VACCINES IN INFANTS IN GERMANY [J].
HEININGER, U ;
CHERRY, JD ;
CHRISTENSON, PD ;
ECKHARDT, T ;
GOERING, U ;
JAKOB, P ;
KASPER, W ;
SCHWEINGEL, D ;
LAUSSUCQ, S ;
HACKELL, JG ;
MEZZATESTA, JR ;
SCOTT, JV ;
STEHR, K .
VACCINE, 1994, 12 (01) :81-86
[7]  
IPP MM, 1989, PEDIATRICS, V83, P679
[8]  
PICHICHERO ME, 1995, PEDIATRICS, V96, P588
[9]  
SALMASO S, 1995, EFFICACY TRIAL ACELL
[10]   Efficacy of acellular pertussis vaccine in early childhood after household exposure [J].
Schmitt, HJ ;
vonKonig, CHW ;
Neiss, A ;
Bogaerts, H ;
Bock, HL ;
SchulteWissermann, H ;
Gahr, M ;
Schult, R ;
Folkens, JU ;
Rauh, W ;
Clemens, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (01) :37-41